Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?

Creative Commons License

Çetin G., Cikrikcioglu M. A., Ozkan T., Karatoprak C., Ar M. C., Eskazan A. E., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.32, sa.3, ss.213-219, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4274/tjh.2013.0336
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.213-219
  • Anahtar Kelimeler: Positron emission tomography, Computed tomography, Bone marrow biopsy, Hodgkin's lymphoma, Non-Hodgkin's lymphoma, FDG-PET, WHOLE-BODY, DISEASE, F-18-FLUORODEOXYGLUCOSE, FLUORODEOXYGLUCOSE, F-18-FDG, CT
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective: Positron emission tomography and computed tomography (PET/CT) has become an important part of staging and treatment evaluation algorithms of lymphoma. We aimed to compare the results of PET/CT with bone marrow biopsy (BMB) with respect to bone marrow involvement (BMI) in patients with Hodgkin's lymphoma (HL) and aggressive non-Hodgkin's lymphoma (aNHL).